Thyroid ultrasound surveillance had low clinical utility among pediatric patients with DTC who exhibited excellent initial treatment response.

PYX-201 has gained FDA fast track designation in recurrent or metastatic head and neck squamous cell carcinoma.

Welcome to the Veracyte fourth quarter and full year 2024 financial results webcast. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the ...

Q4 2024 Earnings Call Transcript February 24, 2025 Veracyte, Inc. beats earnings expectations. Reported EPS is $0.36, ...

The leading Advanced Merkel Cell Carcinoma Companies such as Xencor, Inc., Incyte Corporation, Millennium Pharmaceuticals, ...

Dr. Scott Grady, an endocrinologist at Portland Diabetes & Endocrinology Center (PDEC), is making Thyroid Radiofrequency Ablation (RFA) more accessible to Oregon patients seeking a non-surgical ...

From that, the PRAC has concluded that the data “does not support a causal association” between the drugs and thyroid cancer and sees no need to update the product information at this time.

Feb. 26, 2025 — New findings could help make immunotherapies for brain cancer more effective. The team analyzed almost 200,000 individual immune cells in tumor samples taken from patients with ...

Adults with type 1 diabetes have greater reductions in body weight and HbA1c after using off-label semaglutide or tirzepatide than those not using either drug, according to data published in ...

Lonigutamab (VB-421) is a subcutaneously delivered anti-IGF-1R that is currently being evaluated in a phase 1 study for thyroid eye ... of izokibep can lead to differentiated patient outcomes ...

PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced that Bharatt Chowrira ...